Results 11 to 20 of about 3,273 (206)
Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis [PDF]
Treatment with glucocorticoids is associated with bone loss starting soon after therapy is initiated and an increased risk of fracture.We performed a randomized, double-placebo, double-blind clinical trial of 18 months' duration among patients with a rheumatic disease who were starting glucocorticoids at a daily dose that was equivalent to at least 7.5
Nijs, R.N. de +12 more
core +11 more sources
Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial [PDF]
Osama Sawalmeh,1 Shaheed Moala,1 Zakaria Hamdan,2 Huda Masri,3 Khubaib Ayoub,4 Emad Khazneh,2 Mujahed Shraim5 1Medicine Department, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine; 2Nephrology Department ...
Sawalmeh O +6 more
doaj +3 more sources
Alfacalcidol is an active synthetic preparation of vitamin D, characterized by high bioavailability and broad pharmacological properties. The article substantiates the possibility of widespread use of alfacalcidol in children and adolescents with ...
V. V. Smirnov, S. A. Miroshnichenko
doaj +1 more source
Introduction. The sufficiency of vitamin D is important for slowing down the aging of the skin, maintaining its hydration, elasticity and the ability to regenerate. Biologically active forms of vitamin D (including alfacalcidol) promote the activation of
O. A. Gromova +3 more
doaj +3 more sources
Jun Iwamoto,1 Yoshihiro Sato,2 Mitsuyoshi Uzawa,3 Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, 2Department of Neurology, Mitate Hospital, Fukuoka, 3Department of Orthopaedic Surgery, Keiyu ...
Iwamoto J, Sato Y, Uzawa M, Matsumoto H
doaj +1 more source
Background Secondary hyperparathyroidism is a common feature in patients with chronic kidney disease. Its serious clinical consequences include renal osteodystrophy, calcific uremic arteriolopathy, and vascular calcifications that increase morbidity and ...
Brandi Lisbet +2 more
doaj +2 more sources
Yan Jiang,1,* Zhen-Lin Zhang,2,* Zhong-Lan Zhang,3 Han-Min Zhu,4 Yi-Yong Wu,5 Qun Cheng,4 Feng-Li Wu,5 Xiao-Ping Xing,1 Jian-Li Liu,3 Wei Yu,6 Xun-Wu Meng11Department of Endocrinology, Key Laboratory of Endocrinology, Peking Union Medical College ...
Jiang Y +10 more
doaj +1 more source
Objective To investigate the clinical efficacy of canagliflozin combined with alfacalcidol in the treatment of elderly patients with type 2 diabetes mellitus(T2DM)and osteoporosis. Methods A randomized controlled trial design was adopted.
HUANG Yi*,JIANGXiong,PENG Jun,GUI Xiao,LIU Shuang,LI Peng,LI Yanling,JIANG Meiling
doaj +2 more sources
Jun Iwamoto1, Yoshihiro Sato2, Mitsuyoshi Uzawa3, Tsuyoshi Takeda1, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, Japan; 3Department of ...
Iwamoto J +4 more
doaj +1 more source
Modalities of Vitamin D Administration to Preterm Infants: Impact on 25 OH Vitamin D Levels. [PDF]
Acta Paediatrica, Volume 115, Issue 4, Page 985-987, April 2026.
Laborie S +3 more
europepmc +2 more sources

